Florida Administrative Code
64 - DEPARTMENT OF HEALTH
64B16 - Board of Pharmacy
Chapter 64B16-26 - PHARMACISTS LICENSURE
Section 64B16-26.103 - Continuing Education Credits; Renewal
Universal Citation: FL Admin Code R 64B16-26.103
Current through Reg. 50, No. 187; September 24, 2024
(1) Prior to biennal renewal of pharmacist licensure, a licensee shall complete no less than 30 hours of approved courses of continued professional pharmaceutical education within the 24 month period prior to the expiration date of the license. The following conditions shall apply.
(a) Upon a licensee's first renewal of
licensure, the licensee must document the completion of one (1) hour of board
approved continuing education which includes the topics of Human
Immunodeficiency Virus and Acquired Immune Deficiency Syndrome; the modes of
transmission, including transmission from a healthcare worker to a patient and
the patient to the healthcare worker; infection control procedures, including
universal precautions; epidemiology of the disease; related infections
including tuberculosis (TB); clinical management; prevention; and current
Florida law on AIDS and its impact on testing, confidentiality of test results,
and treatment of patients. In order to meet this requirement, licensees must
demonstrate that the course includes information on the State of Florida law on
HIV/AIDS and its impact on testing, reporting, the offering of HIV testing to
pregnant women, and partner notification issues pursuant to Sections
381.004 and
384.25, F.S. Any HIV/AIDS
continuing education course taken during the second or subsequent renewal of
licensure may be applied to satisfy the general continuing education hours
requirement.
(b) The initial
renewal of a pharmacist license will not require completion of courses of
continued professional pharmaceutical education hours if the license was issued
less than 12 months prior to the expiration date of the license. If the initial
renewal occurs 12 months or more after the initial licensure, then 15 hours of
continued professional pharmaceutical education hours shall be completed prior
to the renewal of the license but no earlier than the date of initial
licensure.
(c) Prior to renewal a
licensee must complete, within the 24 month period prior to the expiration date
of the license, a two-hour continuing education course approved in advance by
the Board on medication errors that covers the study of root-cause analysis,
error reduction and prevention, and patient safety. Hours obtained pursuant to
this section may be applied by the licensee to the requirements of subsection
(1).
(d) Five hours of continuing
education in the subject area of risk management may be obtained by attending
one full day or eight (8) hours of a board meeting at which disciplinary
hearings are conducted by the Board of Pharmacy in compliance with the
following:
1. The licensee must sign in with
the Executive Director or designee of the Board before the meeting day
begins;
2. The licensee must remain
in continuous attendance;
3. The
licensee cannot receive continuing education credit for attendance at a board
meeting if required to appear before the board; and,
4. The maximum continuing education hours
allowable per biennium under this paragraph shall be ten
(10).
(e) A member of the
Board of Pharmacy may obtain five (5) hours of continuing education in the
subject area of risk management for attendance at one Board meeting at which
disciplinary hearings are conducted. The maximum continuing education hours
allowable per biennium under this paragraph shall be ten (10).
(f) Up to five hours per biennium of
continuing education credit may be fulfilled by the performance of volunteer
services to the indigent as provided in Section
456.013(9),
F.S., or to underserved populations, or in areas of critical need within the
state where the licensee practices. In order to receive credit, the licensee
must make application to and receive approval in advance from the Board.
Application shall be made on form DH-MQA 1170 (Rev. 02/09), Individual Request
for Continuing Education for Volunteers, which is hereby incorporated by
reference. The form can be obtained from the Board of Pharmacy, 4052 Bald
Cypress Way, Bin #C04, Tallahassee, Florida 32399-3254. One hour credit shall
be given for each two hours volunteered in the 24 months prior to the
expiration date of the license. In the application for approval, the licensee
shall disclose the type, nature and extent of services to be rendered, the
facility where the services will be rendered, the number of patients expected
to be serviced, and a statement indicating that the patients to be served are
indigent. If the licensee intends to provide services in underserved or
critical need areas, the application shall provide a brief explanation as to
those facts. A licensee who is completing community service as a condition of
discipline imposed by the board cannot use such service to complete continuing
education requirements.
(g)
Continuing education credit shall be granted for completion of post
professional degree programs provided by accredited colleges or schools of
pharmacy. Credit shall be awarded at the rate of 5 hours of continuing
education credit per semester hour completed within the 24 months prior to the
expiration date of the license.
(h)
Continuing education may consist of post-graduate studies, institutes,
seminars, lectures, conferences, workshops, correspondence courses, or other
educational opportunities which advance the practice of the profession of
pharmacy if approved by the Board. A course shall be approved prior to
completion and will be evaluated by the Tripartite Committee using the
standards found in Rule
64B16-26.601, F.A.C. Individuals
must submit requests for course approval at least 45 days in advance of the
program or course by completing the approved application form DOH/MQA/PH 112,
(Rev. 6/12), entitled Individual Requests for Continuing Education Credit,
which is incorporated by reference, and which can be obtained from
http://www.flrules.org/Gateway/reference.asp?No=Ref-01636,
and the Board of Pharmacy, 4052 Bald Cypress Way, Bin #C04, Tallahassee,
Florida 32399-3254, or from the website located at
http://www.doh.state.fl.us/mqa/pharmacy.
Individuals seeking course approval must attach to the application a detailed
program outline, overview or syllabus which describes the educational content,
objectives and faculty qualifications.
(i) Any volunteer expert witness who is
providing expert witness opinions for cases being reviewed by the Department of
Health pursuant to Chapter 465, F.S., shall receive five (5) hours of credit in
the area of risk management for each case reviewed in the 24 months prior to
the expiration date of the license, up to a maximum of ten (10) hours per
biennium.
(j) The presenter of a
live seminar, a live video teleconference or through an interactive
computer-based application shall receive 1 credit for each course credit hour
presented, however presenter will not receive additional credit for multiple
same course presentations.
(k) All
programs approved by the ACPE for continuing education for pharmacists are
deemed approved by the Board for general continuing education hours for
pharmacists. Any course necessary to meet the continuing education requirement
for HIV/AIDS, medication errors, or consultant pharmacist license renewal shall
be Board approved.
(l) General
continuing education earned by a non-resident pharmacist in another state that
is not ACPE approved, but is approved by the board of pharmacy in the state of
residence can be applied to meet the requirements of license renewal in
subsection (1), above.
(m) At least
ten (10) of the required 30 hours must be obtained either at a live seminar, a
live video teleconference, or through an interactive computer-based
application.
(2) Prior to renewal a consultant pharmacist shall complete no less than 24 hours of Board approved continuing education in the course work specified in Rule 64B16-26.302, F.A.C., within the 24 month period prior to the expiration date of the consultant license. The hours earned to satisfy this requirement cannot be used to apply toward the 30 hours required in subsection (1), above. However, if consultant recertification hours are earned and not used to meet the requirements of this paragraph, they may be applied by the licensee to the 30 hours required in subsection (1).
(a) If the initial renewal of a consultant
pharmacist license occurs less than 12 months after the initial licensure, then
completion of consultant courses of continuing education hours will not be
required.
(b) If the initial
renewal of a consultant pharmacist license occurs 12 months or more after the
initial licensure, then 12 hours of consultant continuing education hours must
be completed prior to the renewal date of the license but no earlier than the
date of initial licensure.
(3) Prior to renewal a nuclear pharmacist shall complete no less than 24 hours of Board approved continuing education in the course work specified in Rule 64B16-26.304, F.A.C., within the 24 month period prior to the expiration date of the nuclear pharmacist license. The hours earned to satisfy this requirement cannot be used to apply toward the 30 hours required in subsection (1), above. However, if nuclear pharmacist license renewal hours are earned and not used to meet the requirements of this paragraph, they may be applied by the licensee to the 30 hours required in subsection (1).
(a) If the initial renewal of
a nuclear pharmacist license occurs less than 12 months after the initial
licensure, then completion of courses of nuclear pharmacy continuing education
hours will not be required.
(b) If
the initial renewal of a nuclear pharmacist license occurs 12 months or more
after the initial licensure, then 12 hours of nuclear pharmacy continuing
education hours must be completed prior to the renewal date of the license but
no earlier than the date of initial licensure.
(c) All programs approved by the ACPE for
continuing education for nuclear pharmacists are deemed approved by the Board
for general continuing education hours for nuclear
pharmacists.
(4) Prior to renewal a registered phamacy technician shall complete no less than twenty (20) hours of Board approved continuing education in the course work specified in Rule 64B16-26.355, F.A.C., within the 24 month period prior to the expiration date of the phamacy technician registration. For a registered pharmacy technician that maintains an immunization certification, an additional two (2) hours of continuing education is required in the area of vaccine administration.
(a) Upon a pharmacy technician's first
renewal, registrtant must document the completion of one (1) hour of board
approved continuing education which includes the topics of Human
Immunodeficiency Virus and Acquired Immune Deficiency Syndrome; the modes of
transmission, including transmission from a healthcare worker to a patient and
the patient to the healthcare worker; infection control procedures, including
universal precautions; epidemiology of the disease; related infections
including tuberculosis (TB); clinical management; prevention; and current
Florida law on AIDS and its impact on testing, confidentiality of test results,
and treatment of patients. In order to meet this requirement, licensees must
demonstrate that the course includes information on the State of Florida law on
HIV/AIDS and its impact on testing, reporting, the offering of HIV testing to
pregnant women, and partner notification issues pursuant to Sections
381.004 and
384.25, F.S. Any HIV/AIDS
continuing education course taken during the second or subsequent renewal of
registration may be applied to satisfy the general continuing education hours
requirement.
(b) If the initial
renewal of a pharmacy technician registration occurs less than 12 months after
the initial licensure, then completion of courses of a pharmacy technician
registration education hours will not be required.
(c) If the initial renewal of a pharmacy
techician registration occurs 12 months or more after the initial licensure,
then 12 hours of registered phamacy technician continuing education hours must
be completed prior to the renewal date of the license but no earlier than the
date of initial licensure.
(d) All
programs approved by the ACPE for continuing education for pharmacy technicians
are deemed approved by the Board for general continuing education hours for
registered pharmacy technicians. Any course necessary to meet the continuing
education requirement for HIV/AIDS license renewal shall be Board
approved.
(e) Prior to renewal a
licensee must complete, within the 24 month period prior to the expiration date
of the license, a two-hour continuing education course approved in advance by
the Board on medication errors that covers the study of root-cause analysis,
error reduction and prevention, and patient safety. Hours obtained pursuant to
this section may be applied by the licensee to the requirements of subsection
(1).
(f) Five hours of continuing
education in the subject area of risk management may be obtained by attending
one full day or eight (8) hours of a board meeting at which disciplinary
hearings are conducted by the Board of Pharmacy in compliance with the
following:
1. The registratrant must sign in
with the Executive Director or designee of the Board before the meeting day
begins;
2. The registrant must
remain in continuous attendance;
3.
The registrant cannot receive continuing education credit for attendance at a
board meeting if required to appear before the board; and,
4. The maximum continuing education hours
allowable per biennium under this paragraph shall be ten
(10).
(g) At least four
(4) of the required 20 hours must be obtained either at a live seminar, a live
video teleconference, or through an interactive computer-based
application.
Rulemaking Authority 456.033, 465.009 FS. Law Implemented 456.013(7), (9), 456.033, 465.009, 465.014(7) FS.
New 3-19-79, Formerly 21S-6.07, Amended 1-7-87, Formerly 21S-6.007, Amended 7-31-91, 10-14-91, Formerly 21S-26.103, 61F10-26.103, Amended 7-1-97, Formerly 59X-26.103, Amended 7-11-00, 10-15-01, 1-2-02, 1-12-03, 4-12-05, 5-26-09, 5-27-10, 9-20-12, 10-19-22.
Disclaimer: These regulations may not be the most recent version. Florida may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
